{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T09:10:55Z","timestamp":1781946655121,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T00:00:00Z","timestamp":1542326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Anthrax is primarily recognized as an affliction of herbivores with incubation period ranging from three to five days post-infection. Currently, the Sterne live-spore vaccine is the only vaccine approved for control of the disease in susceptible animals. While largely effective, the Sterne vaccine has several problems including adverse reactions in sensitive species, ineffectiveness in active outbreaks and incompatibility with antibiotics. These can be surmounted with the advent of recombinant peptides (non-living) next generation vaccines. The candidate vaccine antigens comprised of recombinant protective antigen (PA), spore-specific antigen (bacillus collagen-like protein of anthracis, BclA) and formaldehyde inactivated spores (FIS). Presently, little information exists on the protectivity of these novel vaccine candidates in susceptible ruminants. Thus, this study sought to assess the immunogenicity of these vaccine candidates in goats and evaluate their protectivity using an\n                    <jats:italic>in vivo<\/jats:italic>\n                    mouse model. Goats receiving a combination of PA, BclA and FIS yielded the highest antibody and toxin neutralizing titres compared to recombinant peptides alone. This was also reflected in the passive immunization experiment whereby mice receiving immune sera from goats vaccinated with the antigen combination had higher survival post-challenge. In conclusion, the current data indicate promising potential for further development of non-living anthrax vaccines in ruminants.\n                  <\/jats:p>","DOI":"10.1038\/s41598-018-35382-8","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T08:10:06Z","timestamp":1542010206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunogenicity of anthrax recombinant peptides and killed spores in goats and protective efficacy of immune sera in A\/J mouse model"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2958-7151","authenticated-orcid":false,"given":"Okechukwu C.","family":"Ndumnego","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne M.","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannie E.","family":"Crafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"van Heerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,16]]},"reference":[{"key":"35382_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0264-410X(84)90003-3","volume":"2","author":"P Hambleton","year":"1984","unstructured":"Hambleton, P., Carman, J. A. & Melling, J. Anthrax: the disease in relation to vaccines. Vaccine 2, 125\u2013132, https:\/\/doi.org\/10.1016\/0264-410X(84)90003-3 (1984).","journal-title":"Vaccine"},{"key":"35382_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.mam.2009.08.004","volume":"30","author":"W Beyer","year":"2009","unstructured":"Beyer, W. & Turnbull, P. C. Anthrax in animals. Molecular aspects of medicine 30, 481\u2013489, https:\/\/doi.org\/10.1016\/j.mam.2009.08.004 (2009).","journal-title":"Molecular aspects of medicine"},{"key":"35382_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0378-1119(88)90342-3","volume":"64","author":"M Mock","year":"1988","unstructured":"Mock, M., Labruy\u00e8re, E., Glaser, P., Danchin, A. & Ullmann, A. Cloning and expression of the calmodulin-sensitive Bacillus anthracis adenylate cyclase in Escherichia coli. Gene 64, 277\u2013284, https:\/\/doi.org\/10.1016\/0378-1119(88)90342-3 (1988).","journal-title":"Gene"},{"key":"35382_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0378-1119(86)90044-2","volume":"44","author":"DL Robertson","year":"1986","unstructured":"Robertson, D. L. & Leppla, S. H. Molecular cloning and expression in Escherichia coli of the lethal factor gene of Bacillus anthracis. Gene 44, 71\u201378, https:\/\/doi.org\/10.1016\/0378-1119(86)90044-2 (1986).","journal-title":"Gene"},{"key":"35382_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/0092-8674(83)90402-6","volume":"34","author":"MH Vodkin","year":"1983","unstructured":"Vodkin, M. H. & Leppla, S. H. Cloning of the protective antigen gene of Bacillus anthracis. Cell 34, 693\u2013697, https:\/\/doi.org\/10.1016\/0092-8674(83)90402-6 (1983).","journal-title":"Cell"},{"key":"35382_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1099\/00221287-131-2-363","volume":"131","author":"I Uchida","year":"1985","unstructured":"Uchida, I., Sekizaki, T., Hashimoto, K. & Terakado, N. Association of the encapsulation of Bacillus anthracis with a 60 megadalton plasmid. Journal of general microbiology 131, 363\u2013367, https:\/\/doi.org\/10.1099\/00221287-131-2-363 (1985).","journal-title":"Journal of general microbiology"},{"key":"35382_CR7","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/j.1462-5822.2005.00545.x","volume":"7","author":"DJ Banks","year":"2005","unstructured":"Banks, D. J., Barnajian, M., Maldonado\u2010Arocho, F. J., Sanchez, A. M. & Bradley, K. A. Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge. Cellular microbiology 7, 1173\u20131185, https:\/\/doi.org\/10.1111\/j.1462-5822.2005.00545.x (2005).","journal-title":"Cellular microbiology"},{"key":"35382_CR8","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/S0021-9258(17)38364-3","volume":"261","author":"AM Friedlander","year":"1986","unstructured":"Friedlander, A. M. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. Journal of Biological Chemistry 261, 7123\u20137126 (1986).","journal-title":"Journal of Biological Chemistry"},{"key":"35382_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.mam.2009.06.001","volume":"30","author":"WJ Tang","year":"2009","unstructured":"Tang, W. J. & Guo, Q. The adenylyl cyclase activity of anthrax edema factor. Molecular aspects of medicine 30, 423\u2013430, https:\/\/doi.org\/10.1016\/j.mam.2009.06.001 (2009).","journal-title":"Molecular aspects of medicine"},{"key":"35382_CR10","doi-asserted-by":"publisher","unstructured":"Mourez, M. Anthrax toxins. Reviews of physiology, biochemistry and pharmacology, 135\u2013164, https:\/\/doi.org\/10.1007\/s10254-004-0028-2 (2005).","DOI":"10.1007\/s10254-004-0028-2"},{"key":"35382_CR11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1365-2958.2005.04718.x","volume":"57","author":"T Candela","year":"2005","unstructured":"Candela, T. & Fouet, A. Bacillus anthracis CapD, belonging to the \u03b3\u2010glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan. Molecular microbiology 57, 717\u2013726, https:\/\/doi.org\/10.1111\/j.1365-2958.2005.04718.x (2005).","journal-title":"Molecular microbiology"},{"key":"35382_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1086\/341299","volume":"186","author":"S Makino","year":"2002","unstructured":"Makino, S., Watarai, M., Cheun, H., Shirahata, T. & Uchida, I. Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax. Journal of Infectious Diseases 186, 227\u2013233, https:\/\/doi.org\/10.1086\/341299 (2002).","journal-title":"Journal of Infectious Diseases"},{"key":"35382_CR13","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1128\/IAI.01176-07","volume":"76","author":"MD Sutherland","year":"2008","unstructured":"Sutherland, M. D., Thorkildson, P., Parks, S. D. & Kozel, T. R. In vivo fate and distribution of poly-\u03b3-d-glutamic acid, the capsular antigen from Bacillus anthracis. Infection and immunity 76, 899\u2013906, https:\/\/doi.org\/10.1128\/IAI.01176-07 (2008).","journal-title":"Infection and immunity"},{"key":"35382_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1128\/IAI.00764-08","volume":"77","author":"JW Ezzell","year":"2009","unstructured":"Ezzell, J. W. et al. Association of Bacillus anthracis capsule with lethal toxin during experimental infection. Infection and immunity 77, 749\u2013755, https:\/\/doi.org\/10.1128\/IAI.00764-08 (2009).","journal-title":"Infection and immunity"},{"key":"35382_CR15","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1128\/IAI.01145-10","volume":"79","author":"J Jang","year":"2011","unstructured":"Jang, J. et al. The poly-gamma-D-glutamic acid capsule of Bacillus anthracis enhances lethal toxin activity. Infection and immunity 79, 3846\u20133854, https:\/\/doi.org\/10.1128\/IAI.01145-10 (2011).","journal-title":"Infection and immunity"},{"key":"35382_CR16","first-page":"49","volume":"9","author":"M Sterne","year":"1937","unstructured":"Sterne, M. The Effects of Different Carbon Dioxide Concentrations on the Growth of Virulent Anthrax Strains. Pathogenicity and Immunity Tests on Guinea-Pigs and Sheep with Anthrax Variants derived from Virulent Strains. Onderstepoort Journal of Veterinary Science 9, 49\u201367 (1937).","journal-title":"Onderstepoort Journal of Veterinary Science"},{"key":"35382_CR17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2460\/javma.1987.191.06.715","volume":"191","author":"ME Cartwright","year":"1987","unstructured":"Cartwright, M. E., McChesney, A. E. & Jones, R. L. Vaccination-related anthrax in three llamas. J Am Vet Med Assoc 191, 715\u2013716 (1987).","journal-title":"J Am Vet Med Assoc"},{"key":"35382_CR18","first-page":"307","volume":"13","author":"M Sterne","year":"1939","unstructured":"Sterne, M. The use of Anthrax Vaccines Prepared from Avirulent (Uncapsulated) Variants of Bacillus anthracis. Onderstepoort Journal of Veterinary Research 13, 307 (1939).","journal-title":"Onderstepoort Journal of Veterinary Research"},{"key":"35382_CR19","first-page":"359","volume":"56","author":"BK Wobeser","year":"2015","unstructured":"Wobeser, B. K. Anthrax vaccine associated deaths in miniature horses. The Canadian veterinary journal.La revue veterinaire canadienne 56, 359\u2013360 (2015).","journal-title":"The Canadian veterinary journal.La revue veterinaire canadienne"},{"key":"35382_CR20","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1016\/j.vaccine.2004.02.037","volume":"22","author":"PC Turnbull","year":"2004","unstructured":"Turnbull, P. C. et al. Vaccine-induced protection against anthrax in cheetah (Acinonyx jubatus) and black rhinoceros (Diceros bicornis). Vaccine 22, 3340\u20133347, https:\/\/doi.org\/10.1016\/j.vaccine.2004.02.037 (2004).","journal-title":"Vaccine"},{"key":"35382_CR21","doi-asserted-by":"publisher","first-page":"5684","DOI":"10.1016\/j.vaccine.2008.08.026","volume":"26","author":"A Fasanella","year":"2008","unstructured":"Fasanella, A. et al. Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use. Vaccine 26, 5684\u20135688, https:\/\/doi.org\/10.1016\/j.vaccine.2008.08.026 (2008).","journal-title":"Vaccine"},{"key":"35382_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/0264-410X(91)90237-Z","volume":"9","author":"PCB Turnbull","year":"1991","unstructured":"Turnbull, P. C. B. Anthrax vaccines: past, present and future. Vaccine 9, 533\u2013539, https:\/\/doi.org\/10.1016\/0264-410X(91)90237-Z (1991).","journal-title":"Vaccine"},{"key":"35382_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF00189414","volume":"177","author":"PCB Turnbull","year":"1988","unstructured":"Turnbull, P. C. B., Leppla, S. H., Broster, M. G., Quinn, C. P. & Malling, J. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Medical microbiology and immunology 177, 293\u2013303 (1988).","journal-title":"Medical microbiology and immunology"},{"key":"35382_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.vetimm.2016.06.005","volume":"178","author":"OC Ndumnego","year":"2016","unstructured":"Ndumnego, O. C., K\u00f6hler, S. M., Crafford, J., van Heerden, H. & Beyer, W. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model. Veterinary immunology and immunopathology 178, 14\u201321, https:\/\/doi.org\/10.1016\/j.vetimm.2016.06.005 (2016).","journal-title":"Veterinary immunology and immunopathology"},{"key":"35382_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13567-017-0451-4","volume":"48","author":"PH Phaswana","year":"2017","unstructured":"Phaswana, P. H. et al. Use of the mice passive protection test to evaluate the humoral response in goats vaccinated with Sterne 34F2 live spore vaccine. Veterinary research 48, 46, https:\/\/doi.org\/10.1186\/s13567-017-0451-4 (2017).","journal-title":"Veterinary research"},{"key":"35382_CR26","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","volume":"19","author":"ML Pitt","year":"2001","unstructured":"Pitt, M. L. et al. In vitro correlate of immunity in a rabbit model of inhalational anthrax. Vaccine 19, 4768\u20134773, https:\/\/doi.org\/10.1016\/S0264-410X(01)00234-1 (2001).","journal-title":"Vaccine"},{"key":"35382_CR27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.mam.2009.08.006","volume":"30","author":"RJ Cybulski","year":"2009","unstructured":"Cybulski, R. J., Sanz, P. & O\u2019Brien, A. D. Jr. Anthrax vaccination strategies. Molecular aspects of medicine 30, 490\u2013502, https:\/\/doi.org\/10.1016\/j.mam.2009.08.006 (2009).","journal-title":"Molecular aspects of medicine"},{"key":"35382_CR28","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1128\/JB.185.5.1555-1563.2003","volume":"185","author":"P Sylvestre","year":"2003","unstructured":"Sylvestre, P., Couture-Tosi, E. & Mock, M. Polymorphism in the collagen-like region of the Bacillus anthracis BclA protein leads to variation in exosporium filament length. Journal of bacteriology 185, 1555\u20131563, https:\/\/doi.org\/10.1128\/JB.185.5.1555-1563.2003 (2003).","journal-title":"Journal of bacteriology"},{"issue":"52","key":"35382_CR29","doi-asserted-by":"publisher","first-page":"43073","DOI":"10.1074\/jbc.M510087200","volume":"280","author":"St\u00e9phane R\u00e9ty","year":"2005","unstructured":"Rety, S. et al. The crystal structure of the Bacillus anthracis spore surface protein BclA shows remarkable similarity to mammalian proteins. The Journal of biological chemistry 280, 43073\u201343078, M510087200 [pii] (2005).","journal-title":"Journal of Biological Chemistry"},{"key":"35382_CR30","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1128\/IAI.00884-07","volume":"75","author":"TN Brahmbhatt","year":"2007","unstructured":"Brahmbhatt, T. N. et al. Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen. Infection and immunity 75, 5240\u20135247, https:\/\/doi.org\/10.1128\/IAI.00884-07 (2007).","journal-title":"Infection and immunity"},{"key":"35382_CR31","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1016\/j.vaccine.2005.08.031","volume":"24","author":"UK Hahn","year":"2006","unstructured":"Hahn, U. K., Boehm, R. & Beyer, W. DNA vaccination against anthrax in mice-combination of anti-spore and anti-toxin components. Vaccine 24, 4569\u20134571, https:\/\/doi.org\/10.1016\/j.vaccine.2005.08.031 (2006).","journal-title":"Vaccine"},{"key":"35382_CR32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/IAI.70.2.661-664.2002","volume":"70","author":"F Brossier","year":"2002","unstructured":"Brossier, F., Levy, M. & Mock, M. Anthrax spores make an essential contribution to vaccine efficacy. Infection and immunity 70, 661\u2013664, https:\/\/doi.org\/10.1128\/IAI.70.2.661-664.2002 (2002).","journal-title":"Infection and immunity"},{"key":"35382_CR33","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1128\/IAI.01217-08","volume":"77","author":"YP Gauthier","year":"2009","unstructured":"Gauthier, Y. P. et al. Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax. Infection and immunity 77, 1197\u20131207, https:\/\/doi.org\/10.1128\/IAI.01217-08 (2009).","journal-title":"Infection and immunity"},{"key":"35382_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0264-410X(89)90007-8","volume":"7","author":"KH Wiesm\u00fcller","year":"1989","unstructured":"Wiesm\u00fcller, K. H., Jung, G. & Hess, G. Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator. Vaccine 7, 29\u201333, https:\/\/doi.org\/10.1016\/0264-410X(89)90007-8 (1989).","journal-title":"Vaccine"},{"key":"35382_CR35","doi-asserted-by":"crossref","unstructured":"Hoffmann, P. et al. Induction of an epitope-specific humoral immune response by lipopeptide-hapten conjugates: enhancement of the anti-melittin response by a synthetic T helper (Th)-cell epitope. FEMS immunology and medical microbiology 17, 225\u2013234, doi:S0928-8244(97)00010-2 [pii] (1997).","DOI":"10.1016\/S0928-8244(97)00010-2"},{"key":"35382_CR36","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1016\/j.vaccine.2003.11.074","volume":"22","author":"R Spohn","year":"2004","unstructured":"Spohn, R. et al. Synthetic lipopeptide adjuvants and Toll-like receptor 2\u2014structure\u2013activity relationships. Vaccine 22, 2494\u20132499, https:\/\/doi.org\/10.1016\/j.vaccine.2003.11.074 (2004).","journal-title":"Vaccine"},{"key":"35382_CR37","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1016\/j.vaccine.2015.04.049","volume":"33","author":"SM K\u00f6hler","year":"2015","unstructured":"K\u00f6hler, S. M., Baillie, L. W. & Beyer, W. BclA and toxin antigens augment each other to protect NMRI mice from lethal Bacillus anthracis challenge. Vaccine 33, 2771\u20132777, https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.049 (2015).","journal-title":"Vaccine"},{"key":"35382_CR38","doi-asserted-by":"crossref","unstructured":"Mittenbuhler, K., v d Esche, U., Heinevetter, L., Bessler, W. G. & Huber, M. Lipopeptides: adjuvanticity in conventional and genetic immunization. FEMS immunology and medical microbiology 37, 193\u2013200, doi:S0928824403000695 [pii] (2003).","DOI":"10.1016\/S0928-8244(03)00069-5"},{"key":"35382_CR39","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1016\/S0264-410X(01)00197-9","volume":"19","author":"RJ Beedham","year":"2001","unstructured":"Beedham, R. J., Turnbull, P. C. B. & Williamson, E. D. Passive transfer of protection against Bacillus anthracis infection in a murine model. Vaccine 19, 4409\u20134416, https:\/\/doi.org\/10.1016\/S0264-410X(01)00197-9 (2001).","journal-title":"Vaccine"},{"key":"35382_CR40","first-page":"53","volume":"13","author":"M Sterne","year":"1942","unstructured":"Sterne, M., Nicol, J. & Lambrechts, M. C. The effect of large scale active immunization against anthrax. JS Afr.Vet.Med.Assoc 13, 53 (1942).","journal-title":"JS Afr.Vet.Med.Assoc"},{"key":"35382_CR41","doi-asserted-by":"publisher","first-page":"359","DOI":"10.20506\/rst.21.2.1336","volume":"21","author":"ME Hugh-Jones","year":"2002","unstructured":"Hugh-Jones, M. E. & De Vos, V. Anthrax and wildlife. Revue Scientifique et Technique-Office International des Epizooties 21, 359\u2013384 (2002).","journal-title":"Revue Scientifique et Technique-Office International des Epizooties"},{"key":"35382_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0168-1656(95)00092-5","volume":"44","author":"AV Stepanov","year":"1996","unstructured":"Stepanov, A. V., Marinin, L. I., Pomerantsev, A. P. & Staritsin, N. A. Development of novel vaccines against anthrax in man. Journal of Biotechnology 44, 155\u2013160, https:\/\/doi.org\/10.1016\/0168-1656(95)00092-5 (1996).","journal-title":"Journal of Biotechnology"},{"key":"35382_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-017-1140-2","volume":"13","author":"SM Koehler","year":"2017","unstructured":"Koehler, S. M. et al. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions. BMC Veterinary Research 13, 220, https:\/\/doi.org\/10.1186\/s12917-017-1140-2 (2017).","journal-title":"BMC Veterinary Research"},{"key":"35382_CR44","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","volume":"147","author":"S Welkos","year":"2001","unstructured":"Welkos, S., Little, S., Friedlander, A., Fritz, D. & Fellows, P. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology (Reading) 147, 1677\u20131685, https:\/\/doi.org\/10.1099\/00221287-147-6-1677 (2001).","journal-title":"Microbiology (Reading)"},{"key":"35382_CR45","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1046\/j.1365-2672.1999.00897.x","volume":"87","author":"MLM Pitt","year":"1999","unstructured":"Pitt, M. L. M. et al. In vitro correlate of immunity in an animal model of inhalational anthrax. Journal of applied microbiology 87, 304\u2013304, https:\/\/doi.org\/10.1046\/j.1365-2672.1999.00897.x (1999).","journal-title":"Journal of applied microbiology"},{"key":"35382_CR46","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1128\/IAI.00261-07","volume":"75","author":"MT Albrecht","year":"2007","unstructured":"Albrecht, M. T. et al. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax. Infection and immunity 75, 5425\u20135433, https:\/\/doi.org\/10.1128\/IAI.00261-07 (2007).","journal-title":"Infection and immunity"},{"key":"35382_CR47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0882-4010(88)90048-4","volume":"4","author":"SL Welkos","year":"1988","unstructured":"Welkos, S. L. & Friedlander, A. M. Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis. Microbial pathogenesis 4, 53\u201369, https:\/\/doi.org\/10.1016\/0882-4010(88)90048-4 (1988).","journal-title":"Microbial pathogenesis"},{"key":"35382_CR48","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0264-410X(01)00197-9","volume":"3","author":"WG Bessler","year":"2003","unstructured":"Bessler, W. G., Mittenb\u00fchler, K., Esche, U. & Huber, M. Lipopeptide adjuvants in combination treatment. International immunopharmacology 3, 1217\u20131224, https:\/\/doi.org\/10.1016\/S0264-410X(01)00197-9 (2003).","journal-title":"International immunopharmacology"},{"key":"35382_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0165-2427(03)00104-1","volume":"95","author":"JC Hope","year":"2003","unstructured":"Hope, J. C., Whelan, A. O., Hewinson, R. G., Vordermeier, M. & Howard, C. J. Maturation of bovine dendritic cells by lipopeptides. Veterinary immunology and immunopathology 95, 21\u201331, https:\/\/doi.org\/10.1016\/S0165-2427(03)00104-1 (2003).","journal-title":"Veterinary immunology and immunopathology"},{"key":"35382_CR50","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1128\/CVI.00034-08","volume":"15","author":"DN Wedlock","year":"2008","unstructured":"Wedlock, D. N. et al. Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone. Clinical and vaccine immunology: CVI 15, 765\u2013772, https:\/\/doi.org\/10.1128\/CVI.00034-08 (2008).","journal-title":"Clinical and vaccine immunology: CVI"},{"key":"35382_CR51","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.vetimm.2011.09.005","volume":"144","author":"DN Wedlock","year":"2011","unstructured":"Wedlock, D. N., Aldwell, F. E., Vordermeier, H. M., Hewinson, R. G. & Buddle, B. M. Protection against bovine tuberculosis induced by oral vaccination of cattle with Mycobacterium bovis BCG is not enhanced by co-administration of mycobacterial protein vaccines. Veterinary immunology and immunopathology 144, 220\u2013227, https:\/\/doi.org\/10.1016\/j.vetimm.2011.09.005 (2011).","journal-title":"Veterinary immunology and immunopathology"},{"key":"35382_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijmm.2003.12.002","volume":"294","author":"UK Hahn","year":"2004","unstructured":"Hahn, U. K., Alex, M., Czerny, C. P., Bohm, R. & Beyer, W. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination. International journal of medical microbiology: IJMM 294, 35\u201344, https:\/\/doi.org\/10.1016\/j.ijmm.2003.12.002 (2004).","journal-title":"International journal of medical microbiology: IJMM"},{"key":"35382_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1365-2958.1999.01137.x","volume":"31","author":"C Guidi\u2010Rontani","year":"1999","unstructured":"Guidi\u2010Rontani, C., Weber\u2010Levy, M., Labruy\u00e8re, E. & Mock, M. Germination of Bacillus anthracis spores within alveolar macrophages. Molecular microbiology 31, 9\u201317, https:\/\/doi.org\/10.1046\/j.1365-2958.1999.01137.x (1999).","journal-title":"Molecular microbiology"},{"key":"35382_CR54","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/iai.51.3.795-800.1986","volume":"51","author":"SL Welkos","year":"1986","unstructured":"Welkos, S. L., Keener, T. J. & Gibbs, P. H. Differences in susceptibility of inbred mice to Bacillus anthracis. Infection and immunity 51, 795\u2013800 (1986).","journal-title":"Infection and immunity"},{"key":"35382_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0882-4010(89)90108-3","volume":"7","author":"S Welkos","year":"1989","unstructured":"Welkos, S., Trotter, R., Becker, D. & Nelson, G. Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice. Microbial pathogenesis 7, 15\u201335, https:\/\/doi.org\/10.1016\/0882-4010(89)90108-3 (1989).","journal-title":"Microbial pathogenesis"},{"key":"35382_CR56","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.biologicals.2003.09.003","volume":"32","author":"D Hering","year":"2004","unstructured":"Hering, D. et al. Validation of the anthrax lethal toxin neutralization assay. Biologicals 32, 17\u201327, https:\/\/doi.org\/10.1016\/j.biologicals.2003.09.003 (2004).","journal-title":"Biologicals"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35382-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35382-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35382-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:20:55Z","timestamp":1775265655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35382-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,16]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["35382"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-35382-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,16]]},"assertion":[{"value":"12 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16937"}}